These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22512569)

  • 1. Perspectives on the development of novel potentially active quinolones against tuberculosis and cancer.
    Facchinetti V; Gomes CR; de Souza MV; Vasconcelos TR
    Mini Rev Med Chem; 2012 Aug; 12(9):866-74. PubMed ID: 22512569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenanthrolinic analogs of quinolones show antibacterial activity against M. tuberculosis.
    Coulibaly S; Cimino M; Ouattara M; Lecoutey C; Buchieri MV; Alonso-Rodriguez N; Briffotaux J; Mornico D; Gicquel B; Rochais C; Dallemagne P
    Eur J Med Chem; 2020 Dec; 207():112821. PubMed ID: 32950907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel anti-tuberculosis agents with pyrrolo[1,2-a]quinoxaline-based scaffold.
    Wang T; Tang Y; Yang Y; An Q; Sang Z; Yang T; Liu P; Zhang T; Deng Y; Luo Y
    Bioorg Med Chem Lett; 2018 Jun; 28(11):2084-2090. PubMed ID: 29748048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and antitubercular potency of 4-hydroxyquinolin-2(1H)-ones.
    de Macedo MB; Kimmel R; Urankar D; Gazvoda M; Peixoto A; Cools F; Torfs E; Verschaeve L; Lima ES; Lyčka A; Milićević D; Klásek A; Cos P; Kafka S; Košmrlj J; Cappoen D
    Eur J Med Chem; 2017 Sep; 138():491-500. PubMed ID: 28689097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic thioamide, benzimidazole, quinolone and derivatives with carboxylic acid and ester moieties: a strategy in the design of antituberculosis agents.
    Ashfaq M; Shah SS; Najam T; Ahmad MM; Tabassum R; Rivera G
    Curr Med Chem; 2014 Mar; 21(7):911-31. PubMed ID: 24164193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of the newly synthesised ER-2 against clinical isolates of Mycobacterium tuberculosis susceptible or resistant to antituberculosis drugs.
    Rao SS; Raghunathan R; Ekambaram R; Raghunathan M
    Int J Antimicrob Agents; 2009 Nov; 34(5):451-3. PubMed ID: 19625168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinoline: An Attractive Scaffold in Drug Design.
    Moor LFE; Vasconcelos TRA; da R Reis R; Pinto LSS; da Costa TM
    Mini Rev Med Chem; 2021; 21(16):2209-2226. PubMed ID: 33568032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and binary QSAR study of antitubercular quinolylhydrazides.
    Manvar A; Khedkar V; Patel J; Vora V; Dodia N; Patel G; Coutinho E; Shah A
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4896-902. PubMed ID: 23876988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the discovery and development of quinolones and analogs as antitumor agents.
    Xia Y; Yang ZY; Morris-Natschke SL; Lee KH
    Curr Med Chem; 1999 Mar; 6(3):179-94. PubMed ID: 10219099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Easily accessed nitroquinolones exhibiting potent and selective anti-tubercular activity.
    Dube PS; Legoabe LJ; Jordaan A; Jesumoroti OJ; Tshiwawa T; Warner DF; Beteck RM
    Eur J Med Chem; 2021 Mar; 213():113207. PubMed ID: 33524688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinolone hybrids and their anti-cancer activities: An overview.
    Gao F; Zhang X; Wang T; Xiao J
    Eur J Med Chem; 2019 Mar; 165():59-79. PubMed ID: 30660827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and antitubercular activity of 4-alkoxy-triazoloquinolones able to inhibit the M. tuberculosis DNA gyrase.
    Carta A; Bua A; Corona P; Piras S; Briguglio I; Molicotti P; Zanetti S; Laurini E; Aulic S; Fermeglia M; Pricl S
    Eur J Med Chem; 2019 Jan; 161():399-415. PubMed ID: 30384044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of new antitubercular agents--new quinolone agents].
    Kawahara S; Eirei J
    Kekkaku; 1992 Oct; 67(10):679-82. PubMed ID: 1333544
    [No Abstract]   [Full Text] [Related]  

  • 14. Functionalized N(2-oxyiminoethyl) piperazinyl quinolones as new cytotoxic agents.
    Rajabalian S; Foroumadi A; Shafiee A; Emami S
    J Pharm Pharm Sci; 2007; 10(2):153-8. PubMed ID: 17706174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonclassical biological activities of quinolone derivatives.
    Ahmed A; Daneshtalab M
    J Pharm Pharm Sci; 2012; 15(1):52-72. PubMed ID: 22365088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents.
    Suresh Kumar GV; Rajendraprasad Y; Mallikarjuna BP; Chandrashekar SM; Kistayya C
    Eur J Med Chem; 2010 May; 45(5):2063-74. PubMed ID: 20149496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
    Lu J; Yue J; Wu J; Luo R; Hu Z; Li J; Bai Y; Tang Z; Xian Q; Zhang X; Wang H
    Pharmacology; 2010; 85(6):365-71. PubMed ID: 20530976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, diversity-oriented synthesis and structure activity relationship studies of quinolinyl heterocycles as antimycobacterial agents.
    Rachakonda V; Alla M; Kotipalli SS; Ummani R
    Eur J Med Chem; 2013; 70():536-47. PubMed ID: 24189497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, antitubercular and anticancer activities of substituted furyl-quinazolin-3(4H)-ones.
    Raghavendra NM; Thampi P; Gurubasavarajaswamy PM; Sriram D
    Arch Pharm (Weinheim); 2007 Dec; 340(12):635-41. PubMed ID: 17994604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New quinolone antibiotics: a survey of the literature from 2005 to 2010.
    Wiles JA; Bradbury BJ; Pucci MJ
    Expert Opin Ther Pat; 2010 Oct; 20(10):1295-319. PubMed ID: 20645884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.